Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan · Delayed Price · Currency is JPY 6,806.00
-384.00 (-5.34%)
Nov 6, 2026, 3:30 PM JST
Chugai Pharmaceutical Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Chugai Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥8,393. The average 1-year stock price forecast is 23.32% higher than the current stock price, while the lowest is ¥6,100 (-10.37%) and the highest is ¥11,000 (+61.62%).
Price Target: ¥8,393 (+23.32%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Chugai Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 5 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 6 | 5 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Buy Maintains ¥11,100 → ¥11,000 | Buy | Maintains | ¥11,100 → ¥11,000 | +61.62% | Oct 29, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains ¥8,350 | Buy | Maintains | ¥8,350 | +22.69% | Oct 28, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains ¥8,750 | Buy | Maintains | ¥8,750 | +28.56% | Oct 20, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains ¥7,600 → ¥7,300 | Buy | Maintains | ¥7,600 → ¥7,300 | +7.26% | Oct 16, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Maintains ¥7,200 → ¥6,700 | Hold | Maintains | ¥7,200 → ¥6,700 | -1.56% | Oct 14, 2026 |
Financial Forecast
Revenue This Year
1.39T
from 1.26T
Increased by 10.72%
Revenue Next Year
1.52T
from 1.39T
Increased by 9.28%
EPS This Year
309.63
from 263.72
Increased by 17.41%
EPS Next Year
350.55
from 309.63
Increased by 13.21%
Financial currency is JPY.